| Brand Name | Baraclude |
| Generic Name | Entecavir |
| Drug Class | Antiviral (Nucleoside analog) |
| Availability | Prescription |
| Manufacturer | Bristol-Myers Squibb |
| Indications | Chronic hepatitis B |
| Type | Tablet, Oral Solution |
| Doses | 0.5 mg once daily |
| Route | Oral |
| Side Effects | Dizziness, headache, nausea |
| Interactions | HIV meds, nephrotoxic drugs |
| Overdose | Contact poison control |
| Missed Dose | Take as soon as possible unless close to next dose |
| Contraindications | Severe kidney impairment, HIV co-infection |
| Alternatives | Tenofovir, Lamivudine |
| Co-Pay Assistance Program | Available |
| Patient Assistance Program | Available |
Dr. Bharat Pothuri is a Board-Certified Gastroenterologist and Hepatologist. With extensive experience in digestive health, he specializes in advanced endoscopic procedures, chronic GI disorder management, and preventive care. Dr. Pothuri is dedicated to providing expert, patient-focused insights to help improve gut health and overall well-being.
Treats chronic hepatitis B.
On an empty stomach, once daily.
No, it controls but does not cure.
Dizziness, headache, and nausea.
Rare but possible lactic acidosis.
